BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 33682937)

  • 1. Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression.
    Chohan H; Senkevich K; Patel RK; Bestwick JP; Jacobs BM; Bandres Ciga S; Gan-Or Z; Noyce AJ
    Mov Disord; 2021 Jun; 36(6):1420-1429. PubMed ID: 33682937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Type 2 Diabetes in Parkinson's Disease.
    Athauda D; Evans J; Wernick A; Virdi G; Choi ML; Lawton M; Vijiaratnam N; Girges C; Ben-Shlomo Y; Ismail K; Morris H; Grosset D; Foltynie T; Gandhi S
    Mov Disord; 2022 Aug; 37(8):1612-1623. PubMed ID: 35699244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Parkinson's Disease Mendelian Randomization Research Portal.
    Noyce AJ; Bandres-Ciga S; Kim J; Heilbron K; Kia D; Hemani G; Xue A; Lawlor DA; Smith GD; Duran R; Gan-Or Z; Blauwendraat C; Gibbs JR; ; Hinds DA; Yang J; Visscher P; Cuzick J; Morris H; Hardy J; Wood NW; Nalls MA; Singleton AB
    Mov Disord; 2019 Dec; 34(12):1864-1872. PubMed ID: 31659794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Protective Link Between Type I Diabetes and Parkinson's Disease Risk and Progression.
    Senkevich K; Alipour P; Chernyavskaya E; Yu E; Noyce AJ; Gan-Or Z
    Mov Disord; 2023 Jul; 38(7):1350-1355. PubMed ID: 37148456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are neurodegenerative diseases associated with an increased risk of inflammatory bowel disease? A two-sample Mendelian randomization study.
    Cui G; Li S; Ye H; Yang Y; Huang Q; Chu Y; Shi Z; Zhang X
    Front Immunol; 2022; 13():956005. PubMed ID: 36159838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of causality between ADHD and Parkinson's disease: Mendelian randomization study.
    Li GH; Ge GM; Cheung CL; Ip P; Coghill D; Wong IC
    Eur Neuropsychopharmacol; 2020 Aug; 37():49-63. PubMed ID: 32565043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Menopausal Age Reduces the Risk of Parkinson's Disease: A Mendelian Randomization Approach.
    Kusters CDJ; Paul KC; Duarte Folle A; Keener AM; Bronstein JM; Bertram L; Hansen J; Horvath S; Sinsheimer JS; Lill CM; Ritz BR
    Mov Disord; 2021 Oct; 36(10):2264-2272. PubMed ID: 34426982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Causal association between atopic dermatitis and Parkinson's disease: A bidirectional Mendelian randomization study.
    Zhou T; Wei B; Hu Y; Zhou X; Cai X; Shi X
    Brain Behav; 2024 Mar; 14(3):e3468. PubMed ID: 38468488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mendelian randomization study shows no causal relationship between circulating urate levels and Parkinson's disease.
    Kia DA; Noyce AJ; White J; Speed D; Nicolas A; ; Burgess S; Lawlor DA; Davey Smith G; Singleton A; Nalls MA; Sofat R; Wood NW
    Ann Neurol; 2018 Aug; 84(2):191-199. PubMed ID: 30014513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Blood Lipids, Type 2 Diabetes, and Body Mass Index on Parkinson's Disease: A Korean Mendelian Randomization Study.
    Park KW; Hwang YS; Lee SH; Jo S; Chung SJ
    J Mov Disord; 2023 Jan; 16(1):79-85. PubMed ID: 36628424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically Predicted Causality of 28 Gut Microbiome Families and Type 2 Diabetes Mellitus Risk.
    Xiang K; Zhang JJ; Xu YY; Zhong X; Ni J; Pan HF
    Front Endocrinol (Lausanne); 2022; 13():780133. PubMed ID: 35185792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-Wide Association Studies of Cognitive and Motor Progression in Parkinson's Disease.
    Tan MMX; Lawton MA; Jabbari E; Reynolds RH; Iwaki H; Blauwendraat C; Kanavou S; Pollard MI; Hubbard L; Malek N; Grosset KA; Marrinan SL; Bajaj N; Barker RA; Burn DJ; Bresner C; Foltynie T; Wood NW; Williams-Gray CH; Hardy J; Nalls MA; Singleton AB; Williams NM; Ben-Shlomo Y; Hu MTM; Grosset DG; Shoai M; Morris HR
    Mov Disord; 2021 Feb; 36(2):424-433. PubMed ID: 33111402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of Causal Associations of Inflammatory Bowel Disease with Parkinson's Disease and Other Neurodegenerative Disorders.
    Zeng R; Wang J; Zheng C; Jiang R; Tong S; Wu H; Zhuo Z; Yang Q; Leung FW; Sha W; Chen H
    Mov Disord; 2023 Jun; 38(6):1082-1088. PubMed ID: 36959736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causal relationships between Sjögren's syndrome and Parkinson's disease: A Mendelian randomization study.
    Wang J; Li Y; Zhang J; Jiang H; Qi J; Gu Q; Sun Q; Chen L; Jiang Z; Liu A; Ying Z
    Int J Rheum Dis; 2024 Mar; 27(3):e15128. PubMed ID: 38509724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating causal effects of genetically predicted type 2 diabetes on COVID-19 in the East Asian population.
    Yoshikawa M; Asaba K; Nakayama T
    Front Endocrinol (Lausanne); 2022; 13():1014882. PubMed ID: 36568068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bidirectional Mendelian randomization to explore the causal relationships between Sleep traits, Parkinson's disease and Amyotrophic lateral sclerosis.
    Di H; Zhu Y; Xia W; Meng X; Zhang M; Xu M; Feng J; Tian Q; He Y; Cao S; Lu Z
    Sleep Med; 2022 Aug; 96():42-49. PubMed ID: 35594779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers.
    Sugier PE; Lucotte EA; Domenighetti C; Law MH; Iles MM; Brown K; Amos C; McKay JD; Hung RJ; Karimi M; Bacq-Daian D; Boland-Augé A; Olaso R; Deleuze JF; Lesueur F; Ostroumova E; Kesminiene A; de Vathaire F; Guénel P; ; Sreelatha AAK; Schulte C; Grover S; May P; Bobbili DR; Radivojkov-Blagojevic M; Lichtner P; Singleton AB; Hernandez DG; Edsall C; Mellick GD; Zimprich A; Pirker W; Rogaeva E; Lang AE; Koks S; Taba P; Lesage S; Brice A; Corvol JC; Chartier-Harlin MC; Mutez E; Brockmann K; Deutschländer AB; Hadjigeorgiou GM; Dardiotis E; Stefanis L; Simitsi AM; Valente EM; Petrucci S; Straniero L; Zecchinelli A; Pezzoli G; Brighina L; Ferrarese C; Annesi G; Quattrone A; Gagliardi M; Matsuo H; Nakayama A; Hattori N; Nishioka K; Chung SJ; Kim YJ; Kolber P; van de Warrenburg BPC; Bloem BR; Aasly J; Toft M; Pihlstrøm L; Guedes LC; Ferreira JJ; Bardien S; Carr J; Tolosa E; Ezquerra M; Pastor P; Diez-Fairen M; Wirdefeldt K; Pedersen N; Ran C; Belin AC; Puschmann A; Rödström EY; Clarke CE; Morrison KE; Tan M; Krainc D; Burbulla LF; Farrer MJ; Kruger R; Gasser T; Sharma M; ; Truong T; Elbaz A
    Mov Disord; 2023 Apr; 38(4):604-615. PubMed ID: 36788297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic predisposition to Parkinson's disease and risk of cardio and cerebrovascular disease: a Mendelian randomization study.
    Wang M; Zhang Z; Liu D; Ji L; Huang S; Cao L; Wei N; Ye D; Ma Y; Lian X
    Parkinsonism Relat Disord; 2022 Jan; 94():49-53. PubMed ID: 34883359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating the causality of metabolites involved in one-carbon metabolism with the risk and age at onset of Parkinson's disease: A two-sample mendelian randomization study.
    Zhao Y; Tian D; Guo N; Zhang C; Zhu R; Liu X; Zhang J
    Neurobiol Aging; 2021 Dec; 108():196-199. PubMed ID: 34325950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Educational level as a cause of type 2 diabetes mellitus: Caution from triangulation of observational and genetic evidence.
    Na-Ek N; Srithong J; Aonkhum A; Boonsom S; Charoen P; Demakakos P
    Acta Diabetol; 2022 Jan; 59(1):127-135. PubMed ID: 34514530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.